Here's the live share price of Mankind Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mankind Pharma | -5.09 | 4.01 | -3.64 | 17.44 | -2.11 | 10.65 | 10.99 |
| Sun Pharmaceutical Industries | -3.18 | -6.84 | -7.17 | 2.27 | 7.41 | 15.98 | 16.37 |
| Divi's Laboratories | 1.02 | -1.90 | 38.96 | 59.64 | 53.35 | 36.36 | 13.11 |
| Torrent Pharmaceuticals | -1.83 | -5.80 | -3.95 | 16.07 | 31.06 | 35.25 | 24.93 |
| Zydus Lifesciences | -2.62 | -3.03 | -2.94 | 25.09 | 13.09 | 22.91 | 15.19 |
| Laurus Labs | 0.55 | 2.80 | 36.08 | 84.70 | 133.03 | 71.26 | 25.25 |
| Cipla | -3.11 | -5.70 | -8.85 | 7.34 | -12.69 | 4.02 | 7.31 |
| Dr. Reddy's Laboratories | -1.67 | 2.48 | -12.51 | -0.96 | -4.41 | 2.39 | 4.00 |
| Aurobindo Pharma | -1.97 | -2.61 | 5.47 | 22.99 | 53.48 | 21.72 | 18.09 |
| Lupin | -4.29 | -8.05 | -20.97 | -15.33 | 1.90 | 19.11 | 15.44 |
| Alkem Laboratories | 0.02 | 1.07 | -6.54 | -0.11 | -4.57 | 13.88 | 5.83 |
| Glenmark Pharmaceuticals | -5.42 | -10.80 | -0.63 | 1.63 | 14.76 | 41.21 | 33.21 |
| Biocon | -5.90 | -11.09 | -12.07 | -0.29 | 0.09 | 10.23 | -0.56 |
| Abbott India | -4.78 | -0.04 | -2.60 | -1.17 | -14.43 | 3.62 | 3.23 |
| Gland Pharma | 6.83 | 3.74 | 23.16 | 77.53 | 56.95 | 23.75 | -4.44 |
| Anthem Biosciences | 2.22 | -8.85 | 16.60 | 26.55 | 13.36 | 6.13 | 3.63 |
| Ipca Laboratories | -0.69 | -2.07 | 9.43 | 33.30 | 42.29 | 27.22 | 10.55 |
| Ajanta Pharma | -3.83 | -3.86 | 5.05 | 27.13 | 43.03 | 25.47 | 17.62 |
| GlaxoSmithKline Pharmaceuticals | -8.45 | -13.27 | 5.40 | 7.87 | -6.88 | 18.07 | 11.27 |
| Emcure Pharmaceuticals | -4.75 | -3.79 | 2.04 | 18.33 | 33.80 | 10.86 | 6.38 |
Source: Dion Global
Over the last one year, Mankind Pharma has declined 2.11% compared to peers like Sun Pharmaceutical Industries (7.41%), Divi's Laboratories (53.35%), Torrent Pharmaceuticals (31.06%). From a 5 year perspective, Mankind Pharma has underperformed peers relative to Sun Pharmaceutical Industries (16.37%) and Divi's Laboratories (13.11%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,498.4 | 2,492.11 |
| 10 | 2,488.95 | 2,474.23 |
| 20 | 2,402.16 | 2,440.54 |
| 50 | 2,413.91 | 2,420.75 |
| 100 | 2,440.05 | 2,399.91 |
| 200 | 2,298.57 | 2,369.25 |
Source: Dion Global
In the latest quarter, Mankind Pharma saw a drop in promoter holding to 72.61%, while DII stake increased to 15.39%, FII holding fell to 9.45%, and public shareholding moved down to 2.53% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 40,72,930 | 1.79 | 985.32 | |
| 39,00,000 | 1.81 | 943.49 | |
| 27,39,492 | 1.66 | 662.74 | |
| 19,34,592 | 0.86 | 468.02 | |
| 17,70,000 | 1.47 | 428.2 | |
| 16,03,562 | 4.09 | 387.93 | |
| 15,21,556 | 3.79 | 368.09 | |
| 15,07,093 | 5.21 | 364.6 | |
| 14,92,496 | 2.1 | 361.06 | |
| 14,66,270 | 1.19 | 354.72 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 08, 2026, 10:50 PM IST IST | Mankind Pharma - Board Meeting Intimation for Adoption Of Unaudited Financial Results |
| Sep 28, 2026, 09:19 PM IST IST | Mankind Pharma - Resignation Of Statutory Auditors Of A Material WOS |
| Sep 18, 2026, 12:46 AM IST IST | Mankind Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Sep 18, 2026, 12:42 AM IST IST | Mankind Pharma - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Sep 16, 2026, 01:20 AM IST IST | Mankind Pharma - Intimation Regarding ESG Rating |
Source: Dion Global
Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1991PLC044843 and registration number is 044843. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 10421.18 Cr. and Equity Capital is Rs. 41.28 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mankind Pharma is ₹2,398.40 as on Oct 08, 2026.
The Mankind Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Mankind Pharma is ₹99,064.73 Cr as on Oct 08, 2026.
Today’s highest and lowest price of Mankind Pharma are ₹2,497.25 and ₹2,348.90.
The 52-week high/low is the highest and lowest price at which Mankind Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Mankind Pharma is ₹2,640.30 and 52-week low of Mankind Pharma is ₹1,909.90 as on Oct 08, 2026.
The Mankind Pharma has shown returns of -3.87% over the past day, 4.01% for the past month, -3.64% over 3 months, -2.11% over 1 year, 10.65% across 3 years, and 10.99% over 5 years.
P/E ratio of and PB ratio of Mankind Pharma are 48.50 and 5.87 on Oct 08, 2026. While the company gives a dividend yield of 0.04 per annum.
Source: Dion Global